But I am optimistic that scientific studies will be performed,’ says Prof. Publication: Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M.E., Buee, L. & Blum, D. . Beneficial effects of caffeine in a transgenic model of Alzheimer’s disease-like Tau pathology. Neurobiology of Aging.. Caffeine against Alzheimer’s disease As part of a German-French research study, a group led by Dr.The segment benefited from excellent performance within the Specialty Solutions business also. Medical Segment Income for the Medical segment declined 1 % to $2.2 billion, primarily driven by previously disclosed fiscal 2010 customer losses and a strong flu period in the prior-12 months period. Segment profit was $102 million, with the prior year even, resulting from cost reductions that offset the harmful impact of commodity cost increases on the expense of items sold and lower product sales of flu-related products compared to the prior-year period. Segment results were dampened by sluggish in-individual procedural volumes also. ADDITIONAL SECOND-QUARTER AND RECENT HIGHLIGHTS Early renewal of a distribution contract with Walgreens to supply pharmaceuticals to its national network of retail pharmacies.Signed agreements with Highmark Blue Cross Blue Shield, CareFirst and AmeriHealth Blue Cross Blue Shield for P4 Pathways programs.Acceptance of a new, three-year $750 million authorization to repurchase Cardinal Health common shares.